chr1-203683267-A-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000357681.10(ATP2B4):c.62A>C(p.Asp21Ala) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D21N) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000357681.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATP2B4 | NM_001684.5 | c.62A>C | p.Asp21Ala | missense_variant | 2/21 | ENST00000357681.10 | NP_001675.3 | |
ATP2B4 | NM_001001396.3 | c.62A>C | p.Asp21Ala | missense_variant | 2/22 | NP_001001396.1 | ||
ATP2B4 | NM_001365783.2 | c.62A>C | p.Asp21Ala | missense_variant | 2/21 | NP_001352712.1 | ||
ATP2B4 | NM_001365784.2 | c.62A>C | p.Asp21Ala | missense_variant | 2/21 | NP_001352713.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATP2B4 | ENST00000357681.10 | c.62A>C | p.Asp21Ala | missense_variant | 2/21 | 1 | NM_001684.5 | ENSP00000350310 | A1 | |
ATP2B4 | ENST00000341360.7 | c.62A>C | p.Asp21Ala | missense_variant | 2/22 | 1 | ENSP00000340930 | P4 | ||
ATP2B4 | ENST00000705901.1 | c.62A>C | p.Asp21Ala | missense_variant | 2/21 | ENSP00000516177 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 29
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
ATP2B4-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 09, 2022 | The ATP2B4 c.62A>C variant is predicted to result in the amino acid substitution p.Asp21Ala. To our knowledge, this variant has not been reported in the literature or in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.